BioSphere Medical, Inc. Schedules Second Quarter 2009 Financial Results Conference Call July 30

ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ:BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, today announced that it plans to issue its financial results for the second quarter ended June 30, 2009 on July 29 after the close of the stock market. Management will conduct a conference call on Thursday, July 30 at 8:30 a.m. Eastern Time to discuss these results.

Back to news